Cargando…

CD66b(+) neutrophils and α‐SMA(+) fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma

BACKGROUND: Emerging evidence indicates that the tumor microenvironment (TME) influences tumor progression through the various cells it contains. Tumor‐associated neutrophils (TANs) and cancer‐associated fibroblasts (CAFs) are prominent constituents of diverse malignant solid tumors and are crucial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cong, Xiliang, Zhang, Yongle, Zhu, Ziyu, Li, Sen, Yin, Xin, Zhai, Zhao, Zhang, Yu, Xue, Yingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163111/ https://www.ncbi.nlm.nih.gov/pubmed/32096331 http://dx.doi.org/10.1002/cam4.2939

Ejemplares similares

The combination of preoperative fibrinogen and neutrophil-lymphocyte ratio is a predictive prognostic factor in esophagogastric junction and upper gastric cancer
por: Cong, Xiliang, et al.
Publicado: (2019)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
por: Huang, Xiaopei, et al.
Publicado: (2018)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
por: Li, Guanzhang, et al.
Publicado: (2019)

Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Xiang, Zi-jun, et al.
Publicado: (2020)

Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma
por: Zhang, Aibin, et al.
Publicado: (2017)

Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas
por: Zhan, Shenghua, et al.
Publicado: (2020)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
por: Croft, Wayne, et al.
Publicado: (2023)

Elderly Pancreatic Adenocarcinoma Cancer Patients Could Benefit From Postoperative Chemotherapy
por: Xu, Bin, et al.
Publicado: (2023)

CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis
por: Ma, Yan, et al.
Publicado: (2020)

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
por: Arbore, Giuseppina, et al.
Publicado: (2023)

The Ratio of the Hemoglobin to Red Cell Distribution Width Combined with the Ratio of Platelets to Lymphocytes Can Predict the Survival of Patients with Gastric Cancer Liver Metastasis
por: Zhai, Zhao, et al.
Publicado: (2021)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
por: Naso, Julia R., et al.
Publicado: (2020)

Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2017)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2019)

Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
por: Li, Sen, et al.
Publicado: (2019)

Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component
por: Zhu, Ziyu, et al.
Publicado: (2020)

Association of dysbindin expression with individualized postoperative prognosis and chemotherapy benefit among patients with gastric adenocarcinoma
por: Qian, Hao, et al.
Publicado: (2021)

Correction to: Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
por: Li, Sen, et al.
Publicado: (2019)

Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
por: Chen, Jiewei, et al.
Publicado: (2017)

Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Is there a progression‐free survival benefit of first‐line crizotinib versus standard chemotherapy and second‐line crizotinib in ALK‐positive advanced lung adenocarcinoma? A retrospective study of Chinese patients
por: Cui, Shaohua, et al.
Publicado: (2016)

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
por: Roepman, Paul, et al.
Publicado: (2014)

Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study
por: Choi, Jae Eun, et al.
Publicado: (2015)

Value of neutrophil to lymphocyte ratio as a biomarker in colorectal adenocarcinoma
por: Sertoglu, Erdim, et al.
Publicado: (2016)

Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Li, Fazhan, et al.
Publicado: (2021)

Postoperative chemotherapy had no prognostic effect on early‐staged young ovarian cancer with unilateral resection
por: Zhang, Xiaofei, et al.
Publicado: (2018)

Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Chen, Kexin, et al.
Publicado: (2021)

Clinicopathological features and prognoses in younger and older patients with gastric cancer
por: Song, Shubin, et al.
Publicado: (2017)

Appendiceal adenocarcinoma is associated with better prognosis than cecal adenocarcinoma: a population-based comparative survival study
por: Chen, George, et al.
Publicado: (2023)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Identification of hub driving genes and regulators of lung adenocarcinoma based on the gene Co-expression network
por: Xu, Zihao, et al.
Publicado: (2020)

Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs
por: Fang, Weiyuan, et al.
Publicado: (2022)

Patients with ROS1 rearrangement‐positive non‐small‐cell lung cancer benefit from pemetrexed‐based chemotherapy
por: Song, Zhengbo, et al.
Publicado: (2016)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression
por: Shi, Yujia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qum2s8pmuglhqhh25c4k35dla1